CompletedNCT00420823
Taurine for Schizophrenia
This study is completed in Australia. It is testing taurine for Schizophrenia.
In MelbourneSchizophreniaDrugA study involving a medication or substance.From 18 Years to 25 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT01458340
TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study is completed in the United States. It is testing TD-9855 for ADHD.
Multiple locations, including BradentonADHDDrugFrom 18 Years to 45 Years
CompletedNCT00741299
The Association Between Tobacco Smoking and Bipolarity
This study is completed in Israel. It focuses on Bipolarity.
In Tirat HaCarmelBipolarityOtherFrom 18 Years to 65 Years
CompletedNCT00790777
The Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville
This study is completed. It focuses on Schizophrenia.
Location not clearly listedSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT00206102
Cataractogenic Potential of Seroquel and Risperdal for schizophrenia
This study is completed in the United States. It is testing cataractogenic Potential of Seroquel and Risperdal for schizophrenia.
Multiple locations, including Little RockSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT00791167
The Dose Proportionality of Extended Release Paliperidone
This study is completed. It focuses on Schizophrenia.
Location not clearly listedSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT00892125
Safety study of Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in schizophrenia
This study is completed. It is testing Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) for schizophrenia.
Location not clearly listedBipolarity, SchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT00838669
The Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone
This study is completed. It focuses on Schizophrenia.
Location not clearly listedSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT00892320
Safety study of Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Schizophrenia
This study is completed. It is testing Effect of Food on the Pharmacokinetics of ER OROS Paliperidone for Schizophrenia.
Location not clearly listedSchizophreniaDrugFrom 20 Years to 45 Years
CompletedNCT01116830
Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction for schizophrenia
This study is completed in the United States. It is testing Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction for schizophrenia.
In OrangeburgSchizophreniaDrugFrom 18 Years to 65 Years
CompletedNCT00077727
Effectiveness of effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in schizophrenia
This study is completed. It is testing effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment for schizophrenia.
Location not clearly listedSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT06259526
Effectiveness of Effectiveness and Safety of JS1-1-01 in depression
This study is completed in China. It is testing Effectiveness and Safety of JS1-1-01 for depression.
Multiple locations, including BeijingDepressionDrugFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.